SCHEMBL8210401

SCHEMBL8210401

CCC1=C(C(=O)O)C(C)C(C(=O)O)=C(c2ccccc2)N1

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 8/20 0.49
ALDH1A1 P00352 5/20 0.44
CACNA1D Q01668 1/20 0.42
TMIGD3 P0DMS9 1/20 0.38
TRPV1 Q8NER1 3/20 0.37
SMN1; SMN2 Q16637 2/20 0.35
MAPK1 P28482 1/20 0.35
MAPT P10636 2/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
LMNA P02545 1/20 0.34
ALOX12 P18054 1/20 0.34
HTT P42858 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
KDM4E B2RXH2 1/20 0.34
POLB P06746 1/20 0.34
GAA P10253 1/20 0.34
PKM P14618 1/20 0.34
KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7689397 0.77 ADORA3 (0.77) ADORA3ALDH1A1CACNA1DTRPV1HTT
SCHEMBL7386505 0.71 ADORA3 (0.56) ADORA3ALDH1A1CACNA1DTMIGD3TRPV1
SCHEMBL7687629 0.68 ADORA3 (0.75) ADORA3ALDH1A1CACNA1DTMIGD3TRPV1
SCHEMBL19732959 0.66 USP2 (0.56) ALDH1A1SMN1; SMN2POLBKMT2A
SCHEMBL19732960 0.66 USP2 (0.56) ALDH1A1SMN1; SMN2POLBKMT2A
SCHEMBL9870081 0.65 ALDH1A1 (0.41) ADORA3ALDH1A1TMIGD3TRPV1SMN1; SMN2
SCHEMBL10830868 0.61 ABCC1 (0.52) ALDH1A1CACNA1DSMN1; SMN2MAPK1MAPT
Biphenyl SCHEMBL1050110 0.59 SMN1; SMN2 (0.64) ALDH1A1SMN1; SMN2MAPTL3MBTL1LMNA
Biphenyl SCHEMBL15333645 0.59 SMN1; SMN2 (0.64) ALDH1A1SMN1; SMN2MAPTL3MBTL1LMNA
Biphenyl SCHEMBL22163814 0.58 MAPT (0.61) ALDH1A1SMN1; SMN2MAPTL3MBTL1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2000002861-A1 A3 ADENOSINE RECEPTOR ANTAGONISTS THE UNITED STATES OF AMERICA, REPRESENTED BY SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2000-01-20 WO disclosed